Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth Smyth
Cambridge University Hospital NHS - Cambridge, UK
Study Chair - Florian Lordick
Universitaetsklinikum Leipzig-Ambulanzen/Sprechstunden, Leipzig, Germany
Study Chair - Maren Knoedler
Universitaetsklinikum Leipzig-Ambulanzen/Sprechstunden, Leipzig, Germany
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Masaryk Memorial Cancer Institute
Brno, Czechia
- University Hospital Hradec Kralove
Hradec Králové, Czechia
- Chru de Lille - Hopital Huriez
Lille, France
- Hôpital Privé Jean Mermoz
Lyon, France
- Gustave Roussy
Villejuif, France
- Charite - Universitaetsmedizin Berlin
Berlin, Germany
- Kliniken Essen-Mitte
Essen, Germany
- Universitaetsklinikum Freiburg
Freiburg im Breisgau, Germany
- Universitaets Krankenhaus Eppendorf - Universitaetsklinikum Hamburg-Eppendorf Ke - University Cancer Center
Hamburg, Germany
- Slk-Kliniken Heilbronn
Heilbronn, Germany
- Universitaetsklinikum Leipzig-Ambulanzen/sprechstunden
Leipzig, Germany
- Klinikum Rechts Der Isar Der Technische Universitaet Muenchen - Klinikum Rechts Der Isar
München, Germany
- Universitaetsklinikum Tuebingen-Uni Kliniken Berg
Tübingen, Germany
- Rambam Health Care Campus, Oncology Institute
Haifa, Israel
- Rabbin Medical Centre - Tel Aviv
Tel Aviv, Israel
- Azienda Ospedaliera A Papa Giovanni Xxiii
Bergamo, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Istituto Nazionale Tumori Irccs "fondazione G. Pascale"
Naples, Italy
- Oslo University Hospital - Ullevaal Hospital
Oslo, Norway
- Maria Sklodowska-Curie Memorial Cancer Centre
Warsaw, Poland
- Institut Catalan D'Oncologia - Ico Badalona
Badalona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Complejo Hospitalario A
Pamplona, Spain
- Hospital Clinico Universitario de Valencia
Valencia, Spain
- Cambridge University Hospital Nhs
Cambridge, United Kingdom
- Royal Marsden Hospital
London, United Kingdom
- University College London Hospitals Nhs Foundation Trust
London, United Kingdom
- Royal Marsden Hospital
Sutton, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jul 2019
- Primary completion
- 12 Dec 2023
- Completion
- 30 Jun 2026
- Last update posted
- 5 Jan 2024
- Registered enrollment
- 197
- Registry id
- NCT03443856
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.